AL amyloidosis:: Clinical and therapeutic aspects

被引：0

作者：

Merlini, G ^{[1
]}

Anesi, E ^{[1
]}

Banfi, G ^{[1
]}

Baraldi, A ^{[1
]}

Bergesio, F ^{[1
]}

Bertani, T ^{[1
]}

Cavallero, G ^{[1
]}

Conte, N ^{[1
]}

Cossu, M ^{[1
]}

De Luca, M ^{[1
]}

Di Girolamo, M ^{[1
]}

Epis, R ^{[1
]}

Faedda, R ^{[1
]}

Fregoni, V ^{[1
]}

Frigerio, G ^{[1
]}

Frosi, A ^{[1
]}

Furci, L ^{[1
]}

Garini, P ^{[1
]}

Girelli, D ^{[1
]}

Grassi, C ^{[1
]}

Iannaccone, S ^{[1
]}

Imbasciati, E ^{[1
]}

Loni, C ^{[1
]}

Manganaro, M ^{[1
]}

Manno, C ^{[1
]}

Marcenò, R ^{[1
]}

Marenzi, V ^{[1
]}

Marcatti, M ^{[1
]}

Marinone, G ^{[1
]}

Marzani, F ^{[1
]}

Melis, P ^{[1
]}

Miliani, A ^{[1
]}

Montanaro, M ^{[1
]}

Musto, P ^{[1
]}

Palladini, G ^{[1
]}

Parisio, E ^{[1
]}

Pecchini, F ^{[1
]}

Perfetti, V ^{[1
]}

Pintus, F ^{[1
]}

Pozzi, C ^{[1
]}

Quaglini, S ^{[1
]}

Quarenghi, M ^{[1
]}

Schena, FP ^{[1
]}

Tocci, A ^{[1
]}

Uziel, L ^{[1
]}

Ascari, E ^{[1
]}

机构：

[1] Univ Hosp, IRCCS, Policlin S Matteo, I-27100 Pavia, Italy

来源：

AMYLOID AND AMYLOIDOSIS 1998 | 1999年

关键词：

D O I：

暂无

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

页码：142 / 144

页数：3

共 50 条

[41] CRANIOSTENOSIS - CLINICAL AND THERAPEUTIC ASPECTS
DHELLEMMES, P
PELLERIN, P
JOMIN, M
LILLE MEDICAL, 1979, 24 (09): : 716 - 723
[42] The Clinical Features of Multiple Myeloma with AL Amyloidosis
Nashimoto, Junichiro
Nomura, Moe
Irita, Hirofumi
Sato, Kota
Miyazaki, Kanji
Ogura, Mizuki
Abe, Yu
Tsukada, Nobuhiro
Ishida, Tadao
Suzuki, Kenshi
BLOOD, 2020, 136
[43] AMYLOIDOSIS - SOME ASPECTS OF STUDY OF CLINICAL PICTURE AND PATHOGENESIS
TAREEV, EM
VINOGRADOVA, OM
MURKHIN, NA
SEROV, VV
SURA, VV
TERAPEVTICHESKII ARKHIV, 1977, 49 (10) : 119 - 126
[44] Diagnostic and Treatment Strategies for AL Amyloidosis in an Era of Therapeutic Innovation
Dima, Danai
Mazzoni, Sandra
Anwer, Faiz
Khouri, Jack
Samaras, Christy
Valent, Jason
Williams, Louis
JCO ONCOLOGY PRACTICE, 2023, 19 (05) : 265 - +
[45] Targeting protein secretion as a novel therapeutic strategy in AL amyloidosis
Moscvin, Maria
Czarnecki, Peter Gregor
Chen, Tianzeng
Gulla, Annamaria
Anderson, Kenneth Carl
Bianchi, Giada
CANCER RESEARCH, 2022, 82 (12)
[46] Light Chain Stabilization: A Therapeutic Approach to Ameliorate AL Amyloidosis
Morgan, Gareth J.
Buxbaum, Joel N.
Kelly, Jeffery W.
Palladini, Giovanni
HEMATO, 2021, 2 (04): : 645 - 659
[47] APPLICATION OF MONOCLONAL ANTIIDIOTYPES IN THE STUDY OF AL AMYLOIDOSIS - THERAPEUTIC IMPLICATIONS
BELLOTTI, V
STOPPINI, M
PERFETTI, V
ZORZOLI, I
MARINONE, G
MAGGI, A
INVERNIZZI, R
ARBUSTINI, E
MERLINI, G
RENAL FAILURE, 1993, 15 (03) : 365 - 371
[48] AL AMYLOIDOSIS - THERAPEUTIC RESPONSE IN 2 PATIENTS WITH RENAL INVOLVEMENT
GODDARD, IR
JACKSON, R
JONES, JMB
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1991, 6 (08) : 592 - 594
[49] CARDIAC AMYLOIDOSIS - CLINICAL MANIFESTATIONS THERAPEUTIC AND PROGNOSTIC IMPLICATIONS
ARTHUR, JH
VOKONAS, PS
COHEN, AS
HOOD, WB
CIRCULATION, 1973, 48 (04) : 139 - 139
[50] Transthyretin amyloidosis in aortic stenosis: clinical and therapeutic implications
Fabbri, Gioele
Serenelli, Matteo
Cantone, Anna
Sanguettoli, Federico
Rapezzi, Claudio
EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (0E) : E128 - E132

← 1 2 3 4 5 →